Femtech Market

Market Definition

The femtech (female technology) market is the sector of technology and innovation dedicated to developing products, services, and digital solutions that address women's health and wellness needs. This market includes applications, medical devices, wearables, and digital platforms designed to support areas such as reproductive health, menstrual health, maternal care, fertility, contraception, menopause, and broader women’s health needs. The market aims to close gaps in traditional healthcare by providing accessible, inclusive, and tailored solutions for women’s health across different settings, including underserved and humanitarian contexts.

Femtech Market Overview

The global market size was valued at USD 29.32 billion in 2025 and is projected to grow to USD 70.84 billion by 2033, exhibiting a CAGR of 13.43% during the forecast period. The market is experiencing strong growth as healthcare systems, investors, and consumers place greater emphasis on addressing the unique health needs of women. The increasing adoption of digital health technologies further supports this growth.

Mobile applications, telehealth platforms, wearable devices, and connected health solutions are enabling women to access personalized healthcare information, monitor health conditions, and engage with healthcare providers more conveniently and efficiently.

Major companies operating in the global femtech industry are Flo Health Inc., Clue, Natural Cycles, Kindbody, Midi, Inc., Pomelo Care, Inc., Elvie (Willow Innovations, Inc), Ava, Maven Clinic Co., Glow Inc., Inito Inc., Organon group of companies, HeraMED, Carrot, and Hologic, Inc.

Investment activity in the sector has accelerated, supporting the development of new technologies and services tailored to women's healthcare needs. In addition, advances in data analytics, artificial intelligence, and remote monitoring technologies are enhancing the effectiveness of femtech solutions. As healthcare becomes more patient-centric and preventive, femtech is expected to play an increasingly important role in improving health outcomes and expanding access to specialized care for women worldwide.

• In March 2025, the Swedish International Development Cooperation Agency and UNICEF announced a partnership to support the UNICEF Venture Fund femtech initiative (2025-2030). The partnership focuses on accelerating AI and blockchain-based femtech solutions in emerging economies, with an emphasis on Africa and women-led startups, to advance SRHR (sexual, reproductive health and rights) and social impact.

Key Market Highlights

1. The global femtech market size was USD 29.32 billion in 2025.
2. The market is projected to grow at a CAGR of 13.43% from 2026 to 2033.
3. North America held a share of 43.66% in 2025, with a valuation of USD 12.8 billion.
4. The connected hardware and consumer tech segment garnered USD 12.46 billion in revenue in 2025.
5. The pregnancy and nursing segment was valued at USD 8.37 billion in 2025.
6. Asia Pacific is anticipated to grow at a CAGR of 16.76% through the projection period.

How Are The Growing Demand And Awareness Of Women’s Health Solutions Boosting Market Expansion?

Growing demand and awareness of women's health solutions are contributing significantly to market development. As women become more informed about their unique health needs, there is increased interest in solutions tailored to issues like menstrual health, fertility, pregnancy, menopause, and reproductive wellness. Public health campaigns, social media advocacy, and the destigmatization of women’s health topics have empowered more women to seek specialized products and services.

• In February 2026, a high-level WHO parliamentary dialogue emphasized the urgent need for integrated, evidence-based approaches to women’s health and reproductive rights, underscoring global collaboration and political commitment.

This heightened awareness is also prompting healthcare providers and innovators to develop accessible, user-friendly technologies that address gaps in traditional care. As a result, the market is seeing rapid adoption of Femtech solutions, with consumers seeking proactive, personalized, and data-driven tools to manage their health and well-being.

How Does The Lack Of Reliable Data On Women’s Health Hinder The Growth Of The Femtech Market?

Historically, women have been underrepresented in clinical trials and health research, resulting in significant gaps in medical knowledge and product development. This data deficit makes it difficult to design solutions that accurately address the diverse needs of women across different age groups, geographies, and health conditions. It also hinders the ability to validate the effectiveness and safety of femtech products.

To address this challenge, many companies are investing in large-scale, women-centric research initiatives and promoting user participation in data collection through apps and wearables. By prioritizing robust data collection and collaboration with healthcare professionals, these companies aim to deliver evidence-based solutions.

How is the integration of AI and data analytics fostering innovation in the femtech market?

The integration of AI and data analytics is emerging as a notable trend in the femtech market by enabling more personalized and effective women’s health solutions. Artificial intelligence algorithms can analyze vast amounts of health data from wearable devices, apps, and medical records to identify patterns and provide tailored recommendations for users. This capability allows femtech products to offer predictive insights, including ovulation windows, risk factors for certain conditions, and personalized wellness plans.

Data analytics also supports ongoing product improvement and clinical validation, ensuring that solutions meet user needs. By leveraging AI and data-driven insights, femtech companies are enhancing user engagement and trust while empowering women to make more informed decisions about their health and well-being.

• In March 2025, the Embassy of Finland and UNICEF announced a global investment opportunity for tech startups in low- and middle-income countries developing femtech solutions targeting women’s health and socio-economic participation. The UNICEF Venture Fund provides investment and mentoring for open-source innovations using AI and blockchain.

Femtech Market Report Snapshot

 Market Segmentation

• By Product Type (Digital Health and Software, Connected Hardware and Consumer Tech, Clinical Screening and Medical Devices, and Tech-Enabled Clinical Services): The connected hardware and consumer tech segment earned USD 12.46 billion in 2025, primarily due to the growing adoption of wearable devices, home-based health monitoring solutions, fertility trackers, smart breast pumps, and other connected technologies that enable women to manage their health conveniently and in real-time.
• By Application (General Healthcare, Longevity, Menopause Care, Menstrual Health, Mental Health, Pelvic and Uterine Healthcare, Pregnancy and Nursing, Reproductive Health and Contraception, Sexual Health, and Women's Wellness): The pregnancy and nursing segment held a share of 28.54% in 2025, mainly fueled by the increasing demand for prenatal and postnatal care solutions, rising maternal health awareness, growing use of pregnancy tracking applications, and wider adoption of remote monitoring and lactation support technologies.
• By Sales Channel (Direct-to-Consumer (B2C), Enterprise & Corporate Payers (B2B), Healthcare Providers (B2B2C), and Diagnostic & Research Labs): The direct-to-consumer (B2C) segment is projected to grow at a CAGR of 12.51% over the forecast period, owing to rising consumer preference for personalized healthcare solutions, increasing smartphone penetration, greater accessibility of digital health platforms, and the convenience of purchasing women's health products and services directly through online channels.

What is the Market Scenario in North America and Asia Pacific?

Based on region, the global femtech market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

North America femtech market accounted for a share of 43.66% in 2025, with a market value of USD 12.8 billion. The region continues to lead the market due to its advanced healthcare infrastructure, high adoption of digital health solutions, and strong consumer awareness of women’s health issues. The presence of a large number of femtech startups, established healthcare technology companies, and supportive investors has created a favorable environment for innovation.

Demand is particularly strong in areas such as fertility care, pregnancy monitoring, menstrual health, and menopause management. Employers and health insurers are also increasingly incorporating women’s health benefits into their offerings, further supporting regional market expansion. In addition, widespread smartphone usage and growing acceptance of telehealth services have made digital women’s health solutions more accessible.

• In March 2026, the Society of Obstetricians and Gynaecologists of Canada (SOGC) and Femtech Canada announced a strategic partnership to advance women’s health innovation. The collaboration aims to improve care, support clinical education, and accelerate the adoption of technological solutions to enhance health outcomes for women in Canada.

The Asia-Pacific femtech market is expected to grow at a CAGR of 16.76% over the forecast period, making it one of the fastest-growing regional markets globally. Growth is being supported by a large female population, rising healthcare spending, increasing internet penetration, and greater awareness of women’s health and wellness. Countries such as China, India, Japan, and Australia are witnessing growing demand for digital health platforms, fertility services, pregnancy care solutions, and menopause support products.

The rapid adoption of smartphones and mobile health applications has enabled women to access healthcare information and services more conveniently. Governments across the region are also investing in healthcare modernization and digital health initiatives, creating opportunities for femtech companies.

• In September 2025, Temasek Foundation and UNICEF announced a partnership to invest in femtech startups using frontier technology to improve health and well-being for girls and women in Southeast Asia. The initiative provides funding and mentorship and aims to strengthen local innovation ecosystems and address regional health equity gaps.

Regulatory Frameworks

• In the U.S., the Health Insurance Portability and Accountability Act (HIPAA) regulates the privacy and security of medical information. It safeguards sensitive health data managed by femtech apps and devices, requiring robust privacy protections and explicit user consent.
• In the European Union, the Medical Device Regulation (MDR) governs the safety and performance of medical devices. It mandates rigorous testing and compliance for femtech products classified as medical devices before they can be placed on the market.

Competitive Landscape

The femtech market is marked by growing competition, with both emerging startups and established healthcare and technology companies vying for major market share. Startups often lead in developing niche solutions targeting specific aspects of women’s health, including period tracking, fertility, menopause, or sexual wellness. Meanwhile, larger healthcare and technology companies are increasingly focusing on acquisitions, partnerships, or the launch of innovative femtech products.

This growing competition is driving rapid innovation, improved product offerings, and expanded access to women’s health solutions globally. Collaboration among femtech firms, research institutions, and healthcare providers is further accelerating advancements and addressing unmet market needs.

• In January 2026, Qatar Science & Technology Park and Merck launched the QSTP x Merck FemTech Accelerator to support up to 30 high-potential FemTech startups in the MENA region. The program focuses on AI, robotics, and materials science, aiming to advance women’s health innovation and position Qatar as a regional hub.

Key Companies  in The Femtech Market 

• Flo Health Inc.
• Clue
• Natural Cycles
• Kindbody
• Midi, Inc.
• Pomelo Care, Inc.
• Elvie (Willow Innovations, Inc)
• Ava
• Maven Clinic Co.
• Glow Inc.
• Inito Inc.
• Organon group of companies
• HeraMED
• Carrot
• Hologic, Inc.

Recent Developments 

• In May 2026, Solvay and Pantys expanded their partnership with a three-year agreement to scale verified social impact in menstrual health and inclusion. The collaboration uses social credits to measure improvements in daily life, supports product donations and education, and aims to reach 70,000 people and generate 450,000 credits by 2028.

• In September 2025, Spark Biomedical and Velentium Medical launched OhmBody, a discreet, wearable wellness device addressing menstrual pain, heavy bleeding, and related symptoms. This partnership marks Spark Biomedical’s expansion into the femtech space and highlights Velentium Medical’s expertise in medical device design and manufacturing for women’s health innovations.